Data also provided by
J&J strikes $6.5B deal for autoimmune disease specialist Momenta
Johnson & Johnson Executive Committee Vice-Chair and Chief Scientific Officer Dr. Paul Stoffels talks with FOX Business about his company’s coronavirus vaccine development, the plan for distribution when the vaccine is developed and news out of Russia that the county potentially has a vaccine of their own. Johnson & Johnson […]
